Evolving Approaches to Targeted Therapies & Companion Diagnostics
Time: 4:00 pm
day: Day 1 PM
Details:
- Discussing how clinical observations and patient data can be used to refine and develop more accurate tumor models, enhancing their relevance and predictive power
- Highlighting the role of reverse translation in validating clinical biomarkers, ensuring their reliability and utility in predicting patient outcomes
- Leveraging this data to refine patient stratification methods and enhance the design of future clinical trials for improved treatment outcomes
